Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker (CROSBI ID 229680)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Kust, Davor ; Šamija, Ivan ; Kirac, Iva ; Radić, Jasna ; Kovačević, Dujo ; Kusić, Zvonko
engleski
Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker
Objectives: Cytokeratin 20 (CK20) is one of the most investigated markers for the detection of circulating colorectal cancer (CRC) cells by reverse transcription polymerase chain reaction (RT-PCR). The aim of this study was to evaluate prognostic value of RT-PCR detection of circulating CRC cells using CK20 as a marker, and to compare the value of preoperative and postoperative blood sample analysis for that purpose. Methods: Ribonucleic acid (RNA) was isolated from mononuclear cell fraction of blood samples taken from 95 CRC patients before and after tumor resection and from 23 healthy volunteers and assayed by real-time RT-PCR for CK20 expression. Results: In patients positive for CK20 postoperatively both progression-free survival (PFS) and overall survival were significantly shorter than in patients negative for CK20 postoperatively, while the difference between patients positive and negative for CK20 preoperatively was not statistically significant in terms of neither PFS nor overall survival. Conclusion: Our results have shown prognostic value of circulating cancer cells detected in postoperative blood samples from CRC patients using CK20 as marker for RT-PCR, which has potential implications for treatment of these patients. In clinical practice, CK20 expression profile could be a factor in weighting treatment options in CRC patients. In cases where multiple treatment options are possible, patients with positive postoperative CK20 expression could be candidates to receive more aggressive treatment.
biological tumor markers ; circulating neoplastic cells ; cytokeratin-20 ; reverse transcription polymerase chain reaction ; colorectal cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
71 (4)
2016.
235-243
objavljeno
1784-3286
2295-3337
10.1080/17843286.2016.1177264
Povezanost rada
Temeljne medicinske znanosti, Kliničke medicinske znanosti